Topics

EnBrace HR™ Multiphasic Soft Gelatin Capsules | EnBrace HR [JAYMAC Pharmaceuticals, LLC] | BioPortfolio

12:31 EST 27th January 2019 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

EnBrace® HR

with DeltaFolate™

[1 NF Units] [15 mg DFE Folate]

ANTI-ANEMIA PREPARATION as extrinsic/intrinsic factor concentrate plus folate.

Prescription Prenatal/Vitamin Drug For Therapeutic Use

Multi-phasic Capsules (30ct bottle)

NDC 64661-650-30

R Only [DRUG]

GLUTEN-FREE

EnBrace® HR is an orally administered prescription prenatal/vitamin drug for therapeutic use formulated for female macrocytic anemia patients that are in need of treatment, and are under specific direction and monitoring of vitamin B and vitamin B status by a physician.  EnBrace® HR is intended for women of childbearing age who are – or desire to become, pregnant regardless of lactation status. EnBrace® HR may be prescribed for women at risk of depression as a result of folate or cobalamin deficiency - including folate-induced postpartum depression, or are at risk of folate-induced birth defects such as may be found with spina bifida and other neural tube defects (NTDs).

INGREDIENTS
     Cobalamin intrinsic factor complex  1 NF Units National Formulary Units ("NF UNITS") equivalent to 50 mcg of active coenzyme cobalamin (as cobalamin (as cobamamide concentrate with intrinsic factor)
ALSO CONTAINS:
     Folinic acid (B9-vitamer)  2.5 mg 6 mg DFE folate (vitamin B9)
     Control-release, citrated folic acid, DHF+(B9-Provitamin)  1 mg
     Levomefolic acid (B​9​ & B​12​- cofactor)  5.23 mg 9 mg l-methylfolate (molar equivalent)

FUNCTIONAL EXCIPIENTS: 13.6 mg FeGC as ferrous glycine cysteinate (1.5 mg elemental iron ) [colorant], 25 mg ascorbates (24 mg magnesium l-ascorbate, 1 mg zinc l-ascorbate) [antioxidant], at least 23.33 mg phospholipid-omega3 complex [marine lipids], 500 mcg betaine (trimethylglycine) [acidifier], 1 mg magnesium l-threonate [stabilizer].

OTHER EXCIPIENTS: Annatto [colorant], citrates (citric, sodium) [stabilizers], flavin adenine dinucleotide (FAD), gelatin (bovine), glycerine, plant lipids (sunflower) [lecithin], natural orange flavor [masking], nicotinamide adenine dinucleotide hydride (NADH), pyridoxal 5’ phosphate (P5P), piperine [bioavailability enhancer], purified water, thiamine pyrophosphate, ubidecarenone [antioxidant], yellow beeswax.

20% daily value (DV) of VITAMIN C, and 5% DV IRON.

NOT a significant source of magnesium and zinc.

Contains at least 12 mg phosphatidylserine (PS) – of which approximately 6.4 mg as PS-DHA-Ca, and less than 1% EPA (<800 mcg PS-EPA-Ca)

Contains less than 2% (<25 mcg/each) of vitamins B, B, B and B.  

CONTAINS FISH/KRILL/SOY.

Certified 3-party GLUTEN-FREE. No artificial colorants. No dairy, wheat, sugar or egg.

Vitamin B [treatment]; Vitamin B[prevention]; Intrinsic Factor[facilitator].

[Vitamin B ]

Vitamin B deficiency results in megaloblastic anemia, GI lesions, and neurological damage that begins with an inability to produce myelin and is followed by gradual degeneration of the axon and nerve head. Vitamin B has hematopoietic activity apparently identical to that of the anti-anemia factor in purified liver extract.

[Vitamin B ] / [Intrinsic factor]

Gastrointestinal absorption of cobalamin depends on the presence of sufficient intrinsic factor. Intrinsic factor deficiency causes pernicious anemia - which may be associated with subacute combined degeneration of the spinal cord.

[Vitamin B ]

Vitamin B deficiency results in megaloblastic anemia.  Vitamin B stimulates specifically the production of red blood cells, white blood cells, and platelets in persons suffering from certain megaloblastic anemias.

Folic acid, folinic acid and l-methylfolate metabolism results in the creation of tetrahydrofolic acid by different pathways. Both folinic acid and levomefolic acid do not require dihydrofolate reductase (DHR), however folic acid does.

[Vitamin B ] / [Vitamin B ]

Vitamin B is essential for the synthesis of methionine from homocysteine - a reaction which also requires folate. In the absence of Vitamin B, tetrahydrofolate cannot be regenerated from 5-methyltetrahydrofolate, and a functional Vitamin B deficiency occurs (ie, “methyl trap hypothesis”).

EnBrace® HR is indicated in the treatment of macrocytic anemias before, during or after pregnancy - including pernicious anemia and megaloblastic anemia, and the prevention of folic acid deficiency.

Requirements of vitamin B and/or vitamin B in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementation.

USE OF THIS PRODUCT WITHOUT DIRECT SUPERVISION OF A PHYSICIAN IS DANGEROUS. Some patients afflicted with pernicious anemia may or not respond to the orally ingested vitamin B12, and there is no known way to predict which patients may respond and which patients may cease to respond. Periodic examination and laboratory studies of pernicious anemia patients are essential and recommended.  The parenteral administration of (cyano)cobalamin – or vitamin B12, is generally recognized as a fully effective treatment of pernicious anemia. Parenteral alkyl-cobalamin preparations have not been and are not authorized for use except by or on the prescription of a physician.

GENERAL:

0.1 mg or more of folic acid daily may obscure pernicious anemia in that the hematological remission may occur while neurological manifestations remain progressive. The safe tolerable limit for folic acid (in preparations) is 1 mg [emphasis added].

Folic acid is not a substitute for vitamin B - although it may improve vitamin B-deficient megaloblastic anemia. Exclusive use of folic acid in treating vitamin B-deficient megaloblastic anemia could result in progressive and irreversible neurologic damage. Specifically, vitamin B deficiency allowed to progress over 3 months may produce permanent degenerative lesions of the spinal cord - as observed when folate therapy is used as the only hematopoietic agent.

Doses of vitamin B exceeding 10 mcg daily may produce hematologic response in patients with folate deficiency. Indiscriminate administration may mask the true diagnosis.

A dietary deficiency of only vitamin B is rare; multiple vitamin deficiency is expected in any dietary deficiency. No single regimen fits all cases, and the status of the patient observed in follow-up is the final criterion for adequacy of therapy.

DRUG INTERACTIONS:

Colchicine, para-aminosalicylic acid, and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B.

CARCINOGENESIs, MUTAGENESIS, IMPAIRMENT OF FERTILITY:

There is no evidence from long-term use in patients with pernicious anemia that vitamin B or folate is carcinogenic. Pernicious anemia is associated with increased incidence of carcinoma of the stomach, but this is believed to be related to the underlying pathology and not to treatment with vitamin B.

PREGNANCY, NURSING MOTHERS, PEDIATRIC USE:

Vitamin B and vitamin B are essential vitamins and requirements are increased during pregnancy. Amounts of vitamin B and vitamin B that are recommended by the Food and

Nutrition Board, National Academy of Science - National Research Council for lactating women should be consumed during pregnancy.

Vitamin B and vitamin B appear in the milk of nursing mothers in concentrations which approximate the mother’s vitamin B and vitamin B blood level. Amounts of vitamin B that are recommended by the Food and Nutrition Board, National Academies of Science - National Research Council for lactating women should be consumed during lactation.

Intake in pediatric patients should be in the amount recommended by the Food and Nutrition Board, National Academy of Science - National Research Council.

Mild transient diarrhea, polycythemia vera, itching, transitory exanthema, feeling of swelling of entire body may occur with administration of vitamin B. 

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

The adult dose is one capsule daily preferably on an empty stomach.

As a general rule - in patients with Addisonian Pernicious Anemia, treatment will be required for the remainder of the patient’s life. Reticulocyte plasma count, vitamin B and folate must be obtained prior to treatment.

Do not exceed recommended dose. Call your medical practitioner about side effects. You may report side effects by calling 337.662-5962.

Oval, brownish-orange softgel capsule with “ENL” on one side, in bottles of 30 with NDC 64661-650-30.

Oval, brownish-orange softgel capsule with “ENL” on one side, in bottles of 30 with NDC 64661-650-30.

Store at 20°-25°C (68°-77°F). Protect from light and moisture as contact with moisture may produce surface discoloration and/or erosion.

Rx Only [DRUG]

Caution: Federal law prohibits dispensing without a prescription.

KEEP OUT OF THE REACH OF CHILDREN.

Tamper Evident: Do not use if seal is broken or missing .

Upper case.

MANUFACTURED FOR:

JayMac Pharmaceuticals, LLC; Sunset, LA 70584.

MANUFACTURED AND/OR PACKAGED IN USA/CANADA.

PATENTS: 

US Patent No 7,935,365; and other patent applications pending.

TRADEMARKS:

EnBrace® HR is a registered mark of JayMac Pharmaceuticals. DeltaFolate™ is a use-trademark of JayMac Pharmaceuticals.

Revision 3( November 14, 2018 )

NDC 64661-650-30

R Only

with DeltaFolate

EnBrace™HR™

[1 NF Units]

[15 mg DFE Folate]

ANTI-ANEMIA PREPARATION

as extrinsic/intrinsic factor concentrate plus folate.

JAYMAC Pharmaceuticals, LLC

SOFTGEL (30 ct BOTTLE)

Prescription Prenatal/Vitamin Drug

For Therapeutic Use

Manufacturer

JAYMAC Pharmaceuticals, LLC

Active Ingredients

Source

Drugs and Medications [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

EnBrace HR for MDD Relapse Prevention in Women Trying to Conceive and Early Pregnancy

The purpose of this study is to assess to effectiveness of EnBrace HR prenatal supplement as a treatment for the prevention of depression in women with a history of major depressive disord...

EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders

The purpose of this study is to assess a novel nutritional supplement developed for prenatal health and mood benefits, and to determine whether there is preliminary evidence for efficacy i...

PubMed Articles [0 Results]

None

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record